A 52-year-old woman with acute myocardial infarction is admitted to the coronary care unit. She receives aspirin and is being considered for thrombolytic therapy. The cardiologist notes that her troponin I is rising (0.8 ng/mL at 3 hours, 2.1 ng/mL at 6 hours), and her ejection fraction is 35% on echocardiography. She has no contraindications to thrombolysis. However, the interventional cardiology team is 90 minutes away. Which of the following is the most appropriate next step in management?

Explanation

## Clinical Context: Time-Sensitive Reperfusion in STEMI This patient has acute MI with rising troponins, reduced ejection fraction, and no access to primary PCI within the guideline-recommended 90-minute window. The question tests **application of Michaelis-Menten kinetics to thrombolytic efficacy** — understanding why early enzyme activation (thrombolysis) is superior to delayed mechanical reperfusion. ## Michaelis-Menten Kinetics of Fibrinolysis **Key Point:** Thrombolytics activate plasminogen → plasmin, which degrades fibrin clot. The rate of fibrin degradation follows Michaelis-Menten kinetics: $$V = \frac{V_{max} \cdot [Fibrin]}{K_m + [Fibrin]}$$ Where: - **[Fibrin]** = substrate concentration (clot burden) - **V~max~** = maximum plasmin activity - **K~m~** = Michaelis constant (affinity of plasmin for fibrin) **High-Yield:** In the **early phase of MI** (first 3–6 hours), fibrin is actively being deposited, and [Fibrin] is in the linear, non-saturated region of the kinetic curve. Plasmin velocity is **maximally responsive** to substrate changes. Thrombolytics are most effective when administered early because the enzyme–substrate system operates in the steep, efficient portion of the curve. ## Why Early Thrombolysis Is Optimal | Kinetic Principle | Clinical Consequence | |-------------------|----------------------| | **Linear phase kinetics** | Early [Fibrin] is low-to-moderate; plasmin works at high efficiency (V is proportional to [Fibrin]) | | **Substrate responsiveness** | Plasmin degrades clot rapidly when clot is still forming; collateral circulation not yet established | | **Time-dependent efficacy** | Each hour of delay shifts the system toward saturation and established collaterals, reducing reperfusion benefit | | **Guideline: "Door-to-balloon" vs. "Door-to-needle"** | Thrombolysis within 30 min is superior to PCI after 90 min in STEMI without contraindications | **Clinical Pearl:** The **"golden window"** of thrombolytic efficacy (first 3–6 hours) corresponds to the **linear phase of the Michaelis-Menten curve**, where enzyme velocity is most responsive to substrate concentration. Delay moves the system toward saturation (plateau phase), where additional fibrin is degraded slowly. ## Why This Patient Needs Immediate Thrombolysis 1. **Time to PCI > 90 min** → thrombolysis is guideline-preferred 2. **Rising troponins + reduced EF** → large myocardial territory at risk 3. **No contraindications** → benefit outweighs risk 4. **Early administration** → operates in linear kinetic phase (maximum efficacy) 5. **Rescue PCI available** → if thrombolysis fails, mechanical reperfusion is still an option **Mnemonic: STEMI Reperfusion Strategy — "DOOR"** - **D**oor-to-needle (thrombolysis) < 30 min - **O**r door-to-balloon (PCI) < 90 min - **O**r if PCI delayed > 90 min, give thrombolysis - **R**escue PCI if thrombolysis fails